Our Vision
The Babraham Research Campus’ vision is to be one of the best places in the world for discovery bioscience research and innovation and a leading sustainable ecosystem to start, nurture, scale and grow bioscience business. The Campus enables world leading, ground breaking bioscience research and business to come together in a unique combination, through its co-location of bioscience companies with the world leading discovery research of the Babraham Institute. This distinct focus accelerates scientific discovery and helps to build and
scale businesses. Our Campus enables an environment of concept to company and start-up to scale-up all underpinned by the bench to building capabilities that we provide. The result is a highly connected, sustainable and dynamic ecosystem, that creates new discoveries, therapeutics, jobs and growth to support the UK economy. The most recent review of the Campus’ economic impact, published in 2020, showed that overall companies estimated being located on the Campus had on average accelerated their fundraising by
three months and increased the amount of funds raised to date by 10%. In addition, the number of employees is estimated to be around 20% larger than it otherwise may have been as a consequence of being located on Campus. The total market value of the largest fourteen companies on the Campus was calculated to be £4.1bn, which represents a 7.2 times return for investors, who have put in £636m in total. Additional support for early-stage life science start-ups is provided by the Campus’ Accelerate@ Babraham bioincubator programme.
Created out of a desire to support and nurture early-stage life science ventures, Accelerate@Babraham offers ventures the opportunity to experience life as part of one of the most successful locations for life science start-ups in Europe. Recognised by LaBiotech as one of the top 25 biotech incubators in Europe in 2021, the fourth cohort started the programme in September 2021. Since its launch in 2018, Accelerate@Babraham portfolio companies have raised over £12.5m.
Made with FlippingBook. PDF to flipbook with ease